Results 211 to 220 of about 1,598,085 (291)

High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.

American Journal of Clinical Nutrition, 2015
N. Tukvadze, E. Sanikidze, M. Kipiani, Gautam Hebbar, Kirk A Easley, N. Shenvi, R. Kempker, J. Frediani, V. Mirtskhulava, J. Alvarez, N. Lomtadze, L. Vashakidze, Li Hao, C. del Rio, V. Tangpricha, H. Blumberg, T. Ziegler   +16 more
semanticscholar   +1 more source

The Role of Glycoprotein Non‐Metastatic Melanoma Protein B (GPNMB) in Tumors and Other Diseases

MedComm – Oncology, Volume 4, Issue 3, September 2025.
Glycoprotein non‐metastatic melanoma protein B (GPNMB) is is widely involved in biological processes such as tissues, cells, metabolism and immunity, regulates multiple signaling pathways, and plays an important role in the occurrence and development of various diseases, including tumors.
Zhenyu Wu, Na Sun, Man Qu, Xia Kang, Yi Zhang, Xiaowei Qi   +5 more
wiley   +1 more source

A Case Report of Spontaneous Subcutaneous Emphysema Secondary to Pulmonary Tuberculosis. [PDF]

Cureus
Singh M, Vaid M.
europepmc   +1 more source

Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical Trial

Neuropsychopharmacology Reports, Volume 45, Issue 3, September 2025.
The study design focuses on safety and efficacy of oral prednisolone therapy of 1 mg/kg in patients with Fukuyama congenital muscular dystrophy (FCMD). There are considered to be two groups of patients: those with homozygous mutations and those with both homo‐ and heterozygous. The primary endpoints are the changes in motor function evaluated using the
Terumi Murakami, Takatoshi Sato, Takami Ishizuka, Harumasa Nakamura, Hisateru Tachimori, Hiroko Harada, Hideki Oi, Kenji Hatano, Mari S. Oba, Kumiko Ishiguro, Minobu Shichiji, Yuki Kihara, Yasuhiro Takeshima, Mariko Taniguchi‐Ikeda, Ayako Hattori, Yuko Shimizu‐Motohashi, Hiroyuki Awano, Ryosuke Bo, Satoru Nagata, Keiko Ishigaki   +19 more
wiley   +1 more source

Pulmonary Tuberculosis Presenting as Bronchogenic Carcinoma in a Young Ghanaian Adult: A Case Report and Review of the Literature. [PDF]

Clin Case Rep
Appati W, Amenuke DAY, Appati A, Twumasi QO.   +3 more
europepmc   +1 more source

Assessment of Hematological Parameters in Pulmonary Tuberculosis Patients

Indian Journal of Clinical Biochemistry, 2015
K. Rohini, bullet M Surekha Bhat, bullet P S Srikumar, bullet A Mahesh Kumar   +3 more
semanticscholar   +1 more source

Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 9, September 2025.
ABSTRACT Purpose Owing to their rapid antipyretic effects and predictable pharmacokinetic properties, acetaminophen (AAP) are commonly administered intravenously to severely ill patients. However, the potential development of hypotension as a consequence of intravenous AAP administration has not been thoroughly addressed.
Yu‐Ri Choi, Ji‐In Park, Seong‐Sim An, Ji‐Hye Choi, Mi‐Na Min, Jin‐Suk Kang, Jee‐Eun Chung   +6 more
wiley   +1 more source

Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis.

Lancet Glob Health
Ratnakumar S, Hayward SE, Denneny EK, Goldsmith LP, Evans R, Checkley W, Goletti D, Ong CWM, Gotowiec M, Zhu J, Friedland JS, Porter JC.   +11 more
europepmc   +1 more source

Understanding stigma: The experiences of people with drug-sensitive pulmonary tuberculosis in Rawalpindi, Pakistan. [PDF]

PLoS One
Stein R, Fastenau A, Aman H, Ortuño-Gutiérrez N, Schmotzer C, Unterkircher SC, Pilot E.   +6 more
europepmc   +1 more source

Geospatial Distribution of Tuberculosis Incidence and Determinants of Tuberculosis Treatment Outcomes in Nzema East Municipality, Ghana

Public Health Challenges, Volume 4, Issue 3, September 2025.
This study revealed significant spatial clustering of tuberculosis cases in Ghana's Nzema East Municipality, with hotspots in mining and densely populated communities. Treatment success rate (76.7%) fell below WHO targets. Follow‐up laboratory testing and treatment supporters improved outcomes, whereas COVID‐19 period treatments showed increased ...
Charles Afriyie Agyapong, Ali Davod Parsa, Richard Hayhoe, Russell Kabir, Mark Cortnage   +4 more
wiley   +1 more source